Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

2018 Genitourinary Cancers Symposium /
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer

8th - 10th Feb 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.02.18
Views: 595
Rating:

Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK

Dr Choudhury speaks with ecancer at the 2018 ASCO Genitourinary Cancers Symposium about the challenges faced when attempting to select patients who have a poor prognosis.

She goes on to discuss a study looking into the use of a hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation